CD1C and COVID-19: Regarding the CD1c+ gene, studies had shown that the number of CD1c+ myeloid dendritic cells and plasma dendritic cells decreased in patients infected with SARS-CoV-2 even 7 months later, which contributed to a better understanding of the immunological sequelae of COVID-19 (70).